{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T20:40:09Z","timestamp":1777927209402,"version":"3.51.4"},"reference-count":12,"publisher":"SAGE Publications","issue":"7","license":[{"start":{"date-parts":[[2017,12,4]],"date-time":"2017-12-04T00:00:00Z","timestamp":1512345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Int J STD AIDS"],"published-print":{"date-parts":[[2018,6]]},"abstract":"\n We audited whether\n 18<\/jats:sup>\n F-Fluorodeoxyglucose positron emission tomography-computed tomography (\n 18<\/jats:sup>\n FDG PET-CT) imaging could discriminate between different diagnoses in HIV-infected patients presenting with lymphadenopathy, with or without fever and\/or splenomegaly. Maximum standardised uptake (SUV\n max<\/jats:sub>\n ) values were similar in lymphoma and mycobacterial and fungal infections and were lower but similar in those with human herpesvirus (HHV) 8-associated disease and HIV-associated reactive lymphadenopathy. Nodal\n 18<\/jats:sup>\n FDG avidity, with SUV\n max<\/jats:sub>\n \u226510, excluded diagnoses of HHV 8-associated disease and miscellaneous conditions, and HIV-associated reactive lymphadenopathy was additionally excluded in those who had undetectable plasma HIV viral loads. This audit suggests\n 18<\/jats:sup>\n FDG PET-CT imaging did not permit discrimination between specific diagnoses but has utility in identifying lymph nodes with increased avidity that could be targeted for biopsy and in ruling out significant pathology.\n <\/jats:p>","DOI":"10.1177\/0956462417745960","type":"journal-article","created":{"date-parts":[[2017,12,4]],"date-time":"2017-12-04T03:43:34Z","timestamp":1512359014000},"page":"691-694","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":8,"title":["18<\/sup>\n F-Fluorodeoxyglucose positron emission tomography-computed tomography imaging in HIV-infected patients with lymphadenopathy, with or without fever and\/or splenomegaly"],"prefix":"10.1177","volume":"29","author":[{"given":"L","family":"Jain","sequence":"first","affiliation":[{"name":"Central and North West London NHS Foundation Trust, London, UK"},{"name":"T8, University College London Hospitals NHS Foundation Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Mackenzie","sequence":"additional","affiliation":[{"name":"Central and North West London NHS Foundation Trust, London, UK"},{"name":"T8, University College London Hospitals NHS Foundation Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JB","family":"Bomanji","sequence":"additional","affiliation":[{"name":"Institute of Nuclear Medicine, University College London Hospitals NHS Foundation Trust, University College London Hospitals NHS Foundation Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Shortman","sequence":"additional","affiliation":[{"name":"Institute of Nuclear Medicine, University College London Hospitals NHS Foundation Trust, University College London Hospitals NHS Foundation Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Noursadeghi","sequence":"additional","affiliation":[{"name":"T8, University College London Hospitals NHS Foundation Trust, London, UK"},{"name":"Division of Infection and Immunity, University College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SG","family":"Edwards","sequence":"additional","affiliation":[{"name":"Central and North West London NHS Foundation Trust, London, UK"},{"name":"T8, University College London Hospitals NHS Foundation Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RF","family":"Miller","sequence":"additional","affiliation":[{"name":"Central and North West London NHS Foundation Trust, London, UK"},{"name":"T8, University College London Hospitals NHS Foundation Trust, London, UK"},{"name":"Research Department of Infection and Population Health, Institute for Global Health, University College London, London, UK"},{"name":"Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2017,12,4]]},"reference":[{"key":"bibr1-0956462417745960","first-page":"1575","volume":"38","author":"O'Doherty MJ","year":"1997","journal-title":"J Nucl Med"},{"key":"bibr2-0956462417745960","doi-asserted-by":"publisher","DOI":"10.1258\/ijsa.2008.008074"},{"key":"bibr3-0956462417745960","doi-asserted-by":"crossref","unstructured":"Young MPA, Miller RF. Immunosuppression (chapter 16). In: Gray W and Kocjan G (eds)\n Diagnostic cytopathology\n . 3rd ed. London: Elsevier Science, 2010, pp. 471\u2013483.","DOI":"10.1016\/B978-0-7020-3154-0.00016-8"},{"key":"bibr4-0956462417745960","doi-asserted-by":"publisher","DOI":"10.1097\/MNM.0b013e328310b38d"},{"key":"bibr5-0956462417745960","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.12030"},{"key":"bibr6-0956462417745960","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.10.6332"},{"key":"bibr7-0956462417745960","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-008-0998-4"},{"key":"bibr8-0956462417745960","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis193"},{"key":"bibr9-0956462417745960","volume-title":"Evidence-based indications for the use of PET-CT in the UK 2013","author":"Royal College of Physicians\/Royal College of Radiologists\/British Nuclear Medicine Society","year":"2013"},{"key":"bibr10-0956462417745960","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-014-2961-x"},{"key":"bibr11-0956462417745960","doi-asserted-by":"crossref","unstructured":"Bharucha T, Rutherford A, Skeoch S, et al. FDG-PET\/CT in fever of unknown origin working group. Diagnostic yield of FDG-PET\/CT in fever of unknown origin: a systematic review, meta-analysis, and Delphi exercise.\n Clinical Radiol\n 2017; 72: 764\u2013771.","DOI":"10.1016\/j.crad.2017.04.014"},{"key":"bibr12-0956462417745960","doi-asserted-by":"publisher","DOI":"10.1111\/resp.12241"}],"container-title":["International Journal of STD & AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0956462417745960","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/0956462417745960","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0956462417745960","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T22:37:49Z","timestamp":1777675069000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0956462417745960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,4]]},"references-count":12,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["10.1177\/0956462417745960"],"URL":"https:\/\/doi.org\/10.1177\/0956462417745960","relation":{},"ISSN":["0956-4624","1758-1052"],"issn-type":[{"value":"0956-4624","type":"print"},{"value":"1758-1052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,4]]}}}